ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,842.63
1.12%
US Tech 100
19,842.00
-1.19%
다우존스 지수
43,006.59
1.14%
Bitcoin
90,849.92
0.24%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Nuvectis Pharma Inc (NVCT)

  7. Nuvectis Pharma Inc (NVCT) 뉴스

NVCT

Nuvectis Pharma (NVCT)

Nuvectis Pharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:NVCT
일자시간출처헤드라인심볼기업
2025/02/2800:43Business WireMarket News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital MarketsNASDAQ:NVCTNuvectis Pharma Inc
2025/02/2606:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVCTNuvectis Pharma Inc
2025/02/2523:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2025/02/0620:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NVCTNuvectis Pharma Inc
2025/02/0611:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2025/02/0506:31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NVCTNuvectis Pharma Inc
2025/01/0408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2025/01/0408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2025/01/0407:00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVCTNuvectis Pharma Inc
2024/11/2022:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2024/11/0905:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2024/11/0522:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
2024/11/0521:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2024/10/2821:21Business WirePESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data UpdateNASDAQ:NVCTNuvectis Pharma Inc
2024/09/1620:15Business WirePESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to WatchNASDAQ:NVCTNuvectis Pharma Inc
2024/08/2921:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2024/08/0622:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
2024/08/0621:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2024/06/1405:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2024/06/1405:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2024/05/1321:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2024/05/1321:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2024/05/0805:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
2024/05/0722:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2024/03/0607:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVCTNuvectis Pharma Inc
2024/03/0522:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2024/01/0606:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2024/01/0606:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
2023/11/0822:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
2023/11/0821:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
 검색 관련기사 보기:NASDAQ:NVCT

최근 히스토리

NYSE
VZ
Verizon Communications
COIN
DOGEUSD
Dogecoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDGBP
US Dollar vs Sterling
NYSE
NKE
Nike
NYSE
KO
Coca Cola
SPI
SP500
S&P 500
CCOM
US100
US Tech 100
USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지